A Phase II Trial of Belinostat as Consolidation Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Latest Information Update: 22 May 2025
At a glance
- Drugs Belinostat (Primary) ; Zidovudine (Primary) ; Interferon alpha-2b; Peginterferon alfa-2b
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 19 Aug 2024 Planned End Date changed from 31 Dec 2025 to 31 Jul 2025.
- 19 Aug 2024 Status changed from recruiting to active, no longer recruiting.
- 29 Dec 2023 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.